NYSE:BHC

Bausch Health Companies Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy BHC

*Your capital is at risk

$4.95

-0.0600 (-1.20%)

At Close: Jun 03, 2026

Bausch Health Companies Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.17. In total, the insiders bought 95.04M and sold 1.99M BHC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	99.17
● Buy	95.04M shares
● Sell	1.99M shares
77% Buy Activity Weak Negative Correlation
Sell Signal Low Confidence Mar 02, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 99.17. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 22, 2026 Buy	Common Shares, No Par Value A-Award	Garcia Christian A Director	Director	45 871 Value: $250.9K
May 22, 2026 Buy	Common Shares, No Par Value A-Award	Goettler Michael Director	Director	45 871 Value: $250.9K
May 22, 2026 Buy	Common Shares, No Par Value A-Award	Kavanagh Sarah B Director	Director	45 871 Value: $250.9K
May 22, 2026 Buy	Common Shares, No Par Value A-Award	Wechsler Amy B Director	Director	45 871 Value: $250.9K
May 22, 2026 Buy	Common Shares, No Par Value A-Award	Paulson John Director	Director	45 871 Value: $250.9K
May 22, 2026 Buy	Common Shares, No Par Value A-Award	Roberts Eiry Director	Director	45 871 Value: $250.9K
May 22, 2026 Buy	Common Shares, No Par Value A-Award	Power Robert N Director	Director	45 871 Value: $250.9K
May 22, 2026 Buy	Common Shares, No Par Value A-Award	Leung Sandra Director	Director	45 871 Value: $250.9K
May 22, 2026 Buy	Common Shares, No Par Value A-Award	Lee Frank D. Director	Director	45 871 Value: $250.9K
May 19, 2026 Sell	Common Shares, No Par Value S-Sale	Lee Frank D. Director	Director	24 456 Value: $132.8K
May 19, 2026 Buy	Common Stock J-Other	Roberts Eiry	Director	0 Value: $0
Mar 31, 2026 Buy	Common Shares, No Par Value A-Award	Leung Sandra Director	Director	5 946 Value: $32.1K
Mar 31, 2026 Buy	Common Shares, No Par Value A-Award	Paulson John Director	Director	11 574 Value: $62.5K
Mar 31, 2026 Buy	Common Shares, No Par Value A-Award	Wechsler Amy B Director	Director	1 273 Value: $7K
Mar 03, 2026 Sell	Common Shares, No Par Value S-Sale	Carson Seana EVP, General Counsel	Officer	4 420 Value: $25.5K
Mar 02, 2026 Sell	Common Shares, No Par Value J-Other	Appio Thomas Chief Executive Officer	CEO / President	1 137 862 Value: $6.77M
Mar 02, 2026 Sell	Common Shares, No Par Value F-InKind	Appio Thomas Chief Executive Officer	CEO / President	83 705 Value: $498.0K
Mar 02, 2026 Sell	Common Shares, No Par Value S-Sale	Carson Seana EVP, General Counsel	Officer	6 856 Value: $39.6K
Mar 02, 2026 Sell	Common Shares, No Par Value F-InKind	Carson Seana EVP, General Counsel	Officer	16 973 Value: $101.0K
Mar 02, 2026 Sell	Common Shares, No Par Value J-Other	Carson Seana EVP, General Counsel	Officer	137 922 Value: $820.6K
Feb 27, 2026 Sell	Common Shares, No Par Value F-InKind	Charhon Jean-jacques EVP, CFO	C-Suite Officer	49 060 Value: $290.9K
Feb 27, 2026 Sell	Common Shares, No Par Value F-InKind	Carson Seana EVP, General Counsel	Officer	26 326 Value: $156.1K
Feb 27, 2026 Sell	Common Shares, No Par Value F-InKind	Appio Thomas Chief Executive Officer	CEO / President	83 093 Value: $492.7K
Feb 27, 2026 Sell	Common Shares, No Par Value S-Sale	Carson Seana EVP, General Counsel	Officer	8 388 Value: $49.9K
Feb 26, 2026 Sell	Common Shares, No Par Value F-InKind	Charhon Jean-jacques EVP, CFO	C-Suite Officer	35 977 Value: $217.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BAUSCH HEALTH COMPANIES INC.

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on...

Read Full Profile Here